ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 92 filers reported holding ASCENDIS PHARMA A/S in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $250,367 | -6.9% | 2,050 | +0.4% | 0.01% | -69.6% |
| Q2 2021 | $269,000 | -57.0% | 2,042 | -45.6% | 0.02% | -65.2% |
| Q4 2020 | $626,000 | +123.6% | 3,753 | -46.4% | 0.07% | +112.9% |
| Q4 2017 | $280,000 | -12.5% | 6,999 | -20.8% | 0.03% | -61.7% |
| Q3 2017 | $320,000 | +31.1% | 8,832 | +0.4% | 0.08% | +20.9% |
| Q2 2017 | $244,000 | – | 8,800 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
| RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
| Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
| Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
| Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
| Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
| Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
| Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
| Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
| Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |